EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression

Christopher Markosian, Daniela I Staquicini iD, Fenny H F Tang iD, Dawn R Christianson iD, Tracey L Smith, Wadih Arap iD, Renata Pasqualini iD

PNAS Nexus · 30.10.2026 · 5 (11)

DOI: 10.1093/pnasnexus/pgag362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PNAS Nexus, online erschienen am 22.10.2026. Verfasst von Christopher Markosian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Cancer Institute, Newark, NJ 07101, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Levy-Longenbaugh Donor-Advised Fund, Torian Barineau Longenbaugh Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PPP2R1A, the predominant scaffolding subunit of the larger serine/threonine protein phosphatase 2A (PP2A), has been implicated in several solid tumors. Recently, somatic inactivating mutations in PPP2R1A have been shown to be associated with increased intratumoral inflammation and improved survival in patients undergoing dual immune checkpoint blockade for platinum-resistant ovarian clear-cell carcinoma. However, the structural and functional basis for this biological phenomenon has not yet been elucidated. We have previously reported PPP2R1A-mediated heterotypic–homodimeric protein–protein interactions between melanoma cells and lymphatic endothelial cells. Here, we demonstrate that PPP2R1A is also present on the surface of ovarian cancer cells. Moreover, we propose that the disruption of such tumor–lymphatic homodimeric interactions and thereby their interface may potentially be a causative factor for enhanced immune cell enrichment and inflammatory signaling within the tumor microenvironment, ultimately translating to improved survival with immune checkpoint inhibitors.

Schlagwörter

Stichwörter der Autor:innen

PP2Aheterotypic–homodimeric protein–protein interactionimmune checkpoint inhibitorsmelanomaovarian cancer

Autor:innen und Institutionen

  • Rutgers Cancer Institute, Newark, NJ 07101, USA.
  • Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Christianson Consulting, Solana Beach, CA 92075, USA.
  • Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.

ORCID-Profile: Daniela I Staquicini, Fenny H F Tang, Dawn R Christianson, Wadih Arap, Renata Pasqualini

Förderung

  • Levy-Longenbaugh Donor-Advised Fund
  • Torian Barineau Longenbaugh Fund

Zitieren

APA

Markosian, C., Staquicini, D. I., Tang, F. H. F., Christianson, D. R., Smith, T. L., Arap, W., & Pasqualini, R. (2026). PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression. PNAS Nexus, 5(11). https://doi.org/10.1093/pnasnexus/pgag362

Vancouver

Markosian C, Staquicini DI, Tang FHF, Christianson DR, Smith TL, Arap W, et al. PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression. PNAS Nexus. 2026;5(11). doi:10.1093/pnasnexus/pgag362

BibTeX
@article{Markosian2026,
  author = {Markosian, Christopher and Staquicini, Daniela I and Tang, Fenny H F and Christianson, Dawn R and Smith, Tracey L and Arap, Wadih and Pasqualini, Renata},
  title = {PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression},
  journal = {PNAS Nexus},
  year = {2026},
  volume = {5},
  number = {11},
  doi = {10.1093/pnasnexus/pgag362}
}
Kostenlos starten →